Werewolf Therapeutics, Inc.
HOWL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785530
In the last 90 days, Werewolf Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $3.91M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Werewolf Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −1 vs. Q2 2023
- Shares held
- 23.9M
- −161.9K (−0.7%) vs. Q2 2023
- Total value
- $51.1M
- −$22.2M (−30.3%) vs. Q2 2023
- New holders
- 2
- 11 more added
- Sold out
- 3
- 4 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HOWL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $3.91M |
| Q1 2026 | 48 | $11.7M |
| Q4 2025 | 51 | $9.34M |
| Q3 2025 | 62 | $41.6M |
| Q2 2025 | 65 | $24.3M |
| Q1 2025 | 70 | $26.7M |
| Q4 2024 | 73 | $41.7M |
| Q3 2024 | 69 | $68.3M |
| Q2 2024 | 71 | $79.3M |
| Q1 2024 | 61 | $209.7M |
| Q4 2023 | 41 | $106.8M |
| Q3 2023 | 35 | $51.1M |
| Q2 2023 | 36 | $73.3M |
| Q1 2023 | 38 | $62.5M |
| Q4 2022 | 39 | $42.8M |
| Q3 2022 | 44 | $94.5M |
| Q2 2022 | 46 | $78.0M |
| Q1 2022 | 49 | $84.3M |
| Q4 2021 | 51 | $228.4M |
| Q3 2021 | 42 | $326.2M |
| Q2 2021 | 45 | $344.3M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Werewolf Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 6,144,881 | $13.2M | 0.26% | 00.0% | Unchanged |
| MPM Asset Management LLC | 4,284,172 | $9.17M | 4.91% | 00.0% | Unchanged |
| PFM Health Sciences, LP | 2,558,282 | $5.47M | 0.26% | +254,391+11.0% | Added |
| MPM Oncology Impact Management LP | 2,388,011 | $5.11M | 1.36% | 00.0% | Unchanged |
| Rubric Capital Management LP | 1,935,357 | $4.14M | 0.17% | 00.0% | Unchanged |
| Bank of America Corp | 1,531,924 | $3.28M | 0.00% | +2,069+0.1% | Added |
| Adage Capital Partners GP, L.L.C. | 1,000,597 | $2.14M | 0.00% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 626,810 | $1.34M | 0.32% | 00.0% | Unchanged |
| DC Funds, LP | 589,102 | $1.26M | 25.95% | 00.0% | Unchanged |
| Vanguard Group Inc | 547,651 | $1.17M | 0.00% | +83,737+18.1% | Added |
| Laurion Capital Management LP | 522,900 | $1.12M | 0.03% | 00.0% | Unchanged |
| Millennium Management LLC | 466,622 | $998.6K | 0.00% | −392,625−45.7% | Reduced |
| Alyeska Investment Group, L.P. | 397,808 | $851.3K | 0.01% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 174,724 | $373.9K | 0.00% | −151,978−46.5% | Reduced |
| Geode Capital Management, LLC | 174,250 | $373.0K | 0.00% | +8,935+5.4% | Added |
| Bridgeway Capital Management, LLC | 95,511 | $204.4K | 0.00% | +10,000+11.7% | Added |
| Acadian Asset Management LLC | 78,671 | $167.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 77,113 | $165.0K | 0.00% | +3,132+4.2% | Added |
| Dimensional Fund Advisors LP | 58,128 | $124.4K | 0.00% | +33,515+136.2% | Added |
| State Street Corp | 50,768 | $108.6K | 0.00% | 00.0% | Unchanged |
| Edgewood Management LLC | 50,000 | $107.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 45,200 | $97.0K | 0.00% | +2,300+5.4% | Added |
| HBK Sorce Advisory LLC | 26,454 | $56.6K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 26,067 | $55.8K | 0.00% | 00.0% | Unchanged |
| Prudential Financial Inc | 15,400 | $33.0K | 0.00% | −4,400−22.2% | Reduced |
| Simplex Trading, LLC | 5,955 | $12.0K | 0.00% | +5,326+846.7% | Added |
| Financial Perspectives, Inc | 3,750 | $8.03K | 0.00% | +2,500+200.0% | Added |
| Morgan Stanley | 2,500 | $5.35K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,350 | $5.03K | 0.00% | −477−16.9% | Reduced |
| UBS Group AG | 1,000 | $2.14K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 748 | $1.60K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 335 | $1.00K | 0.00% | +335 | New |
| Wells Fargo & Company | 146 | $312 | 0.00% | +10+7.4% | Added |
| GHP Investment Advisors, Inc. | 80 | $185 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 2 | $4 | 0.00% | +2 | New |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −16,537−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −2,100−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −5−100.0% | Sold out |